Alnylam Presents New Pre-clinical Data On ALN-VSP, An RNAi Therapeutic For The Tre...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets...
Medical News Today,
Fri Nov 20 04:39:10 PST 2009
• Found on Yahoo! News
PanGenex Expands Clinical Trial Sites After Promising Pre-Clinical Data About Lowe...
PanGenex Corporation (Pink Sheets: PGCX) ("PanGenex" or "the Company") announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the So...
Medical News Today,
Thu Nov 19 08:40:56 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
Decision to Expand Based Upon Promising Pre-Clinical Results
Marketwire,
Tue Nov 24 05:18:16 PST 2009
• Found on Yahoo! News
TAP delivers customized automated protein purification system in collaboration wit...
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced its Advanced Projects Group has succes...
News-Medical-Net,
Tue Nov 24 03:09:41 PST 2009
• Found on Yahoo! News
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidat...
Pre-Clinical Studies Demonstrate Physiological Activity of CXL-1020
Marketwire,
Wed Nov 18 05:45:56 PST 2009
• Found on Yahoo! News
New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Canc...
News-Medical-Net,
Wed Nov 18 04:43:18 PST 2009
• Found on Yahoo! News
Bio-Quant to be acquired by NexMed
NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has entered into a definitive agreement to acquire Bio-Quant, Inc., a revenue generating priva...
News-Medical-Net,
Mon Nov 23 05:39:43 PST 2009
• Found on Yahoo! News
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidat...
CHAPEL HILL, NC and ORLANDO, FL--(Marketwire - 11/18/09) - Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing therapies for the treatment of cardiovascular ...
Marketwire via Yahoo! Finance,
Wed Nov 18 05:30:00 PST 2009
• Found on Yahoo! News
PanGenex Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lowe...
TAMPA, Fla.----PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South , the Company will extend its t...
Business Wire via Yahoo! Finance,
Wed Nov 18 08:00:00 PST 2009
• Found on Yahoo! News
Pre-clinical data of GM1485 to be presented by GliaMed
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstr...
News-Medical-Net,
Wed Nov 18 00:57:40 PST 2009
• Found on Yahoo! News
(AFX UK Focus) 2009-11-20 11:19 BRIEF-Inovio Biomedical flu vaccines shows immune ...
Nov 20 (Reuters) - Inovio Biomedical Corp:
Interactive Investor,
Fri Nov 20 03:26:43 PST 2009
• Found on Yahoo! News
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, t...
redOrbit,
Tue Nov 24 07:10:28 PST 2009
• Found on Yahoo! News
Innovation Award for GMI presented at the 2009 World Congress on Medical Physics
Gamma Medica-Ideas, Inc., a leading developer of digital molecular imaging systems, announced today that it has been awarded an Innovation Award for its new prototype imaging system that co...
News-Medical-Net,
Tue Nov 24 06:09:33 PST 2009
• Found on Yahoo! News
Jubilant Organosys forms JV with UAB & Southern Research Institute
Jubilant Organosys has entered a Memorandum of Understanding (MoU) in Washington, DC with the University of Alabama at Birmingham (UAB), and Southern Research Institute for a joint venture ...
PharmaBiz,
Tue Nov 24 04:06:25 PST 2009
• Found on Yahoo! News
Gamma Medica-Ideas Wins Industry Innovation Award From the World Congress on Medic...
NORTHRIDGE, CA--(Marketwire - November 24, 2009) - Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has been awarded an In...
Marketwire,
Tue Nov 24 05:14:47 PST 2009
• Found on Yahoo! News
Fourth-quarter and full year fiscal 2009 results announced by AVANIR Pharmaceutica...
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.
News-Medical-Net,
Tue Nov 24 06:24:33 PST 2009
• Found on Yahoo! News
Ception Therapeutics And Cephalon Provide Initial Results Of A Phase IIb/III Study...
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) ...
Medical News Today,
Tue Nov 24 04:36:35 PST 2009
• Found on Yahoo! News
Gamma Medica-Ideas Wins Industry Innovation Award From the World Congress on Medic...
NORTHRIDGE, CA--(Marketwire - 11/24/09) - Gamma Medica-Ideas, Inc. ("GMI"), a leading developer of digital molecular imaging systems, announced today that it has been awarded an Innovation ...
Marketwire via Yahoo! Finance,
Tue Nov 24 05:00:00 PST 2009
• Found on Yahoo! News
Biolaxy Secures IND Approval for Oral Insulin
Shanghai Biolaxy announced the Chinese State Food & Drug Administration has approved the investigational new drug application for its oral insulin project , an innovative insulin formulatio...
PR Newswire via Yahoo! Finance,
Tue Nov 24 07:30:00 PST 2009
• Found on Yahoo! News